This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Fuso Pharmaceutical Industries, Ltd.. Active years: 2000-2013.
Location History:
- Osaka, JP (2004)
- Ibaraki, JP (2000 - 2009)
- Hokkaido, JP (2009)
- Asahikawa, JP (2007 - 2013)
Company Filing History:
Years Active: 2000-2013
Title: **Innovative Contributions of Nobutaka Wakamiya in Medical Science**
Introduction
Nobutaka Wakamiya, an accomplished inventor based in Asahikawa, Japan, has made significant strides in the field of medical sciences. With a portfolio of 14 patents, he is dedicated to developing innovative treatments for various health conditions.
Latest Patents
Wakamiya's recent patents demonstrate his commitment to addressing critical health issues. One notable invention is a polypeptide designed to enhance the treatment of ischemic diseases. This polypeptide is crucial in developing reagents or medicines for the prevention and treatment of ischemic disorders, particularly those caused by arteriosclerosis. It contains at least one part with an amino acid sequence that improves expression levels in mammalian blood vessels subjected to ischemic conditions through blood reperfusion.
Another important patent from Wakamiya pertains to isolated collectin genes and proteins. He has provided genes that include specific base sequences expected to have antibacterial and antiviral activity, particularly beneficial within the human body. This pioneering work in isolates—such as collectin (CL-L2s) proteins—illustrates his focus on enhancing human health through innovative biotechnology.
Career Highlights
Wakamiya is currently affiliated with Fuso Pharmaceutical Industries, Ltd., where his research and inventions play a pivotal role in advancing medical therapies. His career is marked by a passion for scientific discovery, leading to impactful innovations that push the boundaries of contemporary medicine.
Collaborations
Throughout his career, Wakamiya has worked alongside esteemed colleagues, including Hiroyuki Keshi and Katsuki Ohtani. These collaborations foster a productive environment for research, leading to groundbreaking advancements in therapeutic applications and strengthening the collective effort towards innovation in the pharmaceutical field.
Conclusion
Nobutaka Wakamiya's contributions to medical science through his innovative inventions reflect his dedication to improving health outcomes. His work not only addresses current medical challenges but also sets the foundation for future advancements in treatment methodologies. As an inventor, he continues to inspire and push the boundaries of scientific inquiry in the quest for better healthcare solutions.